I know this probably goes against typical bogleheads practices but I recently came across a start-up looking to raise capital that piqued my interest. The short version is I have a son with multiple special needs diagnoses for which there are no cures. This start-up has a treatment that could potentially be game changing in this space. So far they have 2 clinical trials published with positive results and minimal side effects. They are looking to raise capital to power a phase 3 clinical trial in order to seek FDA approval in 2025. They've already raised 75% of the funds needed to do this. The are looking for qualified investors to invest anywhere from $25,000 to $1,000,000. I am considering going in at the $25,000 level because if they can get this approved, it will be be helpful on a personal level to my son who is unable to participate in the trial. The sooner this treatment comes to market, the better. Of course, there could also be a financial benefit here. I will attend a potential investors meeting next week before making any final decisions. What are some of the questions I should ensure are answered before making a decision?
The trials were conducted at Arizona State University and they were awarded a patent. The FDA has also granted them "Fast-track" status
The treatment isn't an actual drug so pharma companies would likely not be interested in supporting until there is a clear business model.
The trials were conducted at Arizona State University and they were awarded a patent. The FDA has also granted them "Fast-track" status
The treatment isn't an actual drug so pharma companies would likely not be interested in supporting until there is a clear business model.
Statistics: Posted by iexaltu — Sat Aug 24, 2024 10:06 am — Replies 10 — Views 384